Xiangui Hu

797 total citations
27 papers, 627 citations indexed

About

Xiangui Hu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Xiangui Hu has authored 27 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Xiangui Hu's work include Pancreatic and Hepatic Oncology Research (15 papers), Neuroendocrine Tumor Research Advances (6 papers) and MicroRNA in disease regulation (6 papers). Xiangui Hu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (15 papers), Neuroendocrine Tumor Research Advances (6 papers) and MicroRNA in disease regulation (6 papers). Xiangui Hu collaborates with scholars based in China. Xiangui Hu's co-authors include Chenghao Shao, Jun Hao, Shuyu Zhang, Yingqi Zhou, Cong Liu, Gang Jin, Jundong Zhou, Fang Xie, Jinchang Wu and Jian Tong and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Xiangui Hu

25 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiangui Hu China	15	433	338	234	98	67	27	627
Yingqi Zhou China	12	358 0.8×	225 0.7×	204 0.9×	112 1.1×	65 1.0×	20	577
Jue‐Yu Zhou China	15	426 1.0×	278 0.8×	110 0.5×	38 0.4×	41 0.6×	42	591
Jiagen Li China	15	447 1.0×	370 1.1×	199 0.9×	93 0.9×	30 0.4×	42	756
Sen Guo China	14	361 0.8×	202 0.6×	172 0.7×	166 1.7×	30 0.4×	27	560
Deyuan Fu China	14	359 0.8×	326 1.0×	168 0.7×	44 0.4×	29 0.4×	35	614
Dianke Chen China	13	299 0.7×	257 0.8×	186 0.8×	53 0.5×	49 0.7×	25	519
Shifeng Xu China	12	239 0.6×	177 0.5×	143 0.6×	61 0.6×	49 0.7×	22	456
Yingxi Mo China	16	393 0.9×	280 0.8×	107 0.5×	42 0.4×	31 0.5×	36	580
Fanfei Kong China	15	422 1.0×	378 1.1×	151 0.6×	34 0.3×	40 0.6×	26	626
Zhi-Qiang Meng China	12	214 0.5×	126 0.4×	213 0.9×	62 0.6×	77 1.1×	16	483

Countries citing papers authored by Xiangui Hu

Since Specialization

Citations

This map shows the geographic impact of Xiangui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangui Hu more than expected).

Fields of papers citing papers by Xiangui Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangui Hu. The network helps show where Xiangui Hu may publish in the future.

Co-authorship network of co-authors of Xiangui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangui Hu. A scholar is included among the top collaborators of Xiangui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangui Hu. Xiangui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ouyang, Liu, Hao Hu, Zhiping Huang, et al.. (2022). Incidence of bifid pancreatic duct in pancreaticoduodenectomy and its impact on clinically relevant postoperative pancreatic fistula. Frontiers in Oncology. 12. 934978–934978.

Li, Bo, Xiaoyi Yin, Suizhi Gao, et al.. (2022). Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. International Journal of Surgery. 104. 106786–106786. 4 indexed citations

Ouyang, Liu, Rendong Liu, Tianlin He, et al.. (2022). Nomogram predicts CR-POPF in open central pancreatectomy patients with benign or low-grade malignant pancreatic neoplasms. Frontiers in Oncology. 12. 2 indexed citations

Ouyang, Liu, et al.. (2021). MiR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer. Annals of Translational Medicine. 9(24). 1798–1798. 17 indexed citations

Chen, Danlei, et al.. (2017). Risk factors and managements of hemorrhage associated with pancreatic fistula after pancreaticoduodenectomy. Hepatobiliary & pancreatic diseases international. 16(5). 537–544. 17 indexed citations

Peng, Cheng, Yunfeng Wang, Gang Li, et al.. (2015). Interplay between menin and Dnmt1 reversibly regulates pancreatic cancer cell growth downstream of the Hedgehog signaling pathway. Cancer Letters. 370(1). 136–144. 23 indexed citations

Song, Bin, Qi Bian, Gang Li, et al.. (2015). Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy. PLoS ONE. 10(3). e0120694–e0120694. 21 indexed citations

Song, Bin, Qi Bian, Yijie Zhang, et al.. (2015). Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation. Molecular Cancer. 14(1). 177–177. 43 indexed citations

Shao, Zhuo, et al.. (2015). The role of fast-track surgery in pancreaticoduodenectomy: A retrospective cohort study of 635 consecutive resections. International Journal of Surgery. 15. 129–133. 29 indexed citations

10.

Liu, An‐An, Chenghao Shao, Gang Jin, et al.. (2014). miR-208-Induced Epithelial to Mesenchymal Transition of Pancreatic Cancer Cells Promotes Cell Metastasis and Invasion. Cell Biochemistry and Biophysics. 69(2). 341–346. 31 indexed citations

11.

Shao, Chenghao, Gang Jin, Rui Liu, et al.. (2014). Downregulation of CPE regulates cell proliferation and chemosensitivity in pancreatic cancer. Tumor Biology. 35(12). 12459–12465. 15 indexed citations

12.

Jin, Gang, Zhuo Shao, Xiangui Hu, et al.. (2013). Efficacy and prognosis analysis of 2061 cases of pancreatic cancer resection. 13(1). 1–4. 4 indexed citations

13.

Jing, Wei, Tianlin He, Xiangui Hu, et al.. (2012). The clinical efficacy and safety of modified Miwa's augmented regional pancreatoduodenectomy in the treatment of ductal adenocarcinoma of the pancreas in the uncinate process.. PubMed. 60(122). 268–72. 3 indexed citations

14.

Peng, Cheng, Gang Jin, Xiangui Hu, et al.. (2012). Analysis of tumor‐induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus. Cancer Science. 103(10). 1756–1763. 17 indexed citations

15.

Jing, Wei, Guanghui Zhu, Xiangui Hu, et al.. (2012). Distal Pancreatectomy with En Bloc Celiac Axis Resection for the Treatment of Locally Advanced Pancreatic Body and Tail Cancer. Hepatogastroenterology. 60(121). 187–90. 14 indexed citations

16.

Zhang, Shuyu, Jun Hao, Fang Xie, et al.. (2011). Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis. 32(8). 1183–1189. 132 indexed citations

17.

Hao, Jun, Shuyu Zhang, Yingqi Zhou, et al.. (2011). MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochemical and Biophysical Research Communications. 406(4). 552–557. 88 indexed citations

18.

Hao, Jun, Shuyu Zhang, Yingqi Zhou, Xiangui Hu, & Chenghao Shao. (2010). MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Letters. 585(1). 207–213. 92 indexed citations

19.

Jin, Gang, Shu Wang, Xiangui Hu, et al.. (2003). Characterization of the tissue-specific expression of the S100P gene which encodes an EF-hand Ca2+-binding protein*. Molecular Biology Reports. 30(4). 243–248. 11 indexed citations

20.

Xi, Pengcheng, et al.. (2003). Clinical analysis of uncinate process carcinoma of the pancreas.. PubMed. 2(4). 605–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact